Status:
COMPLETED
Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception
Lead Sponsor:
Pfizer
Conditions:
Contraception
Bone Density
Eligibility:
FEMALE
12-18 years
Phase:
PHASE4
Brief Summary
To evaluate and compare Bone Mineral Density (BMD) in adolescent Depo-Provera Contraceptive Injection (DP150CI) users during depo medroxyprogesterone acetate (DMPA) therapy and following discontinuati...
Eligibility Criteria
Inclusion
- Adolescent females who have had any menses in the 6 months prior to enrollment
- Must have a negative pregnancy test
Exclusion
- Concomitant medication exclusion use of bone modifying agents, glucocorticoids, heparin, and anticonvulsants
- Screening Spinal BMD with z score not greater than -2 of matched young normals
Key Trial Info
Start Date :
April 1 1998
Trial Type :
INTERVENTIONAL
End Date :
July 1 2007
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00139685
Start Date
April 1 1998
End Date
July 1 2007
Last Update
September 25 2008
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Los Angeles, California, United States
2
Pfizer Investigational Site
Palo Alto, California, United States
3
Pfizer Investigational Site
Torrance, California, United States
4
Pfizer Investigational Site
Louisville, Kentucky, United States